ImmunoGen Balance Sheet Health

Financial Health criteria checks 4/6

ImmunoGen has a total shareholder equity of $561.6M and total debt of $72.1M, which brings its debt-to-equity ratio to 12.8%. Its total assets and total liabilities are $822.1M and $260.5M respectively.

Key information

12.8%

Debt to equity ratio

US$72.11m

Debt

Interest coverage ration/a
CashUS$605.54m
EquityUS$561.60m
Total liabilitiesUS$260.51m
Total assetsUS$822.10m

Recent financial health updates

Recent updates

Final Countdown: AbbVie's Imminent Closure With ImmunoGen And What It Means

Feb 09

ImmunoGen, Inc.'s (NASDAQ:IMGN) Intrinsic Value Is Potentially 40% Above Its Share Price

Jan 09
ImmunoGen, Inc.'s (NASDAQ:IMGN) Intrinsic Value Is Potentially 40% Above Its Share Price

There's Reason For Concern Over ImmunoGen, Inc.'s (NASDAQ:IMGN) Massive 95% Price Jump

Dec 22
There's Reason For Concern Over ImmunoGen, Inc.'s (NASDAQ:IMGN) Massive 95% Price Jump

ImmunoGen (NASDAQ:IMGN) Is Using Debt Safely

Oct 20
ImmunoGen (NASDAQ:IMGN) Is Using Debt Safely

Analysts Just Made A Massive Upgrade To Their ImmunoGen, Inc. (NASDAQ:IMGN) Forecasts

Aug 06
Analysts Just Made A Massive Upgrade To Their ImmunoGen, Inc. (NASDAQ:IMGN) Forecasts

Is ImmunoGen, Inc. (NASDAQ:IMGN) Trading At A 48% Discount?

Jul 20
Is ImmunoGen, Inc. (NASDAQ:IMGN) Trading At A 48% Discount?

Forecast: Analysts Think ImmunoGen, Inc.'s (NASDAQ:IMGN) Business Prospects Have Improved Drastically

May 03
Forecast: Analysts Think ImmunoGen, Inc.'s (NASDAQ:IMGN) Business Prospects Have Improved Drastically

ImmunoGen, Inc.'s (NASDAQ:IMGN) Low P/S No Reason For Excitement

Apr 18
ImmunoGen, Inc.'s (NASDAQ:IMGN) Low P/S No Reason For Excitement

Is ImmunoGen (NASDAQ:IMGN) In A Good Position To Deliver On Growth Plans?

Feb 25
Is ImmunoGen (NASDAQ:IMGN) In A Good Position To Deliver On Growth Plans?

What Does The Future Hold For ImmunoGen, Inc. (NASDAQ:IMGN)? These Analysts Have Been Cutting Their Estimates

Jan 03
What Does The Future Hold For ImmunoGen, Inc. (NASDAQ:IMGN)? These Analysts Have Been Cutting Their Estimates

Financial Position Analysis

Short Term Liabilities: IMGN's short term assets ($766.9M) exceed its short term liabilities ($134.7M).

Long Term Liabilities: IMGN's short term assets ($766.9M) exceed its long term liabilities ($125.8M).


Debt to Equity History and Analysis

Debt Level: IMGN has more cash than its total debt.

Reducing Debt: IMGN's debt to equity ratio has increased from 4.4% to 12.8% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IMGN has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if IMGN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.